Trestle Biotherapeutics
YC W21Bioengineered kidneys for patients with kidney failure
San Diego, CA, USAFounded 20212 employeeswww.trestlebio.com
Team
2
Founded
2021
About
We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.
Tags
No open roles at this time.
Similar Healthcare startups
Recover
Government-funded online addiction treatment
Open Jobs —
Team 10
Founded 2021
Entelexo Biotherapeutics
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
Biotech
Open Jobs —
Team 3
Founded 2021
Zealth
Software for remote monitoring of cancer patients
Health TechRemoteOncology
Open Jobs —
Team 2
Founded 2021
Origami Therapeutics, Inc.
Oral drugs to halt neurodegeneration
BiotechTherapeuticsDrug discovery
Open Jobs —
Team 4
Founded 2022